Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|February 23, 2013
Solvatochromic and single crystal studies of 3-(4-bromophenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-1-carbaldehydePramod Singh, B S Rawat, Jagmohan S Negi, et al.Journal of Clinical Medicine|April 12, 2025
The Current Landscape of Clinical TrialsGeeta Joshi, Tara K Bhandari, Pushkar Joshi, et al.Urologic Oncology|September 28, 2025
Small renal masses: Where do we stand? An updated analysis of trends and outcomes from the SEER database (2000-2021)Ahmad Abdelaziz, Sarah Al Omari, Ahmet Urkmez, et al.Plos One|August 2, 2024
Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insightsAmanda Watson, Pankil Shah, Doug Lee, et al.Genome Biology|March 21, 2007
Reactome: a knowledge base of biologic pathways and processesImre Vastrik, Peter D'Eustachio, Esther Schmidt, et al.Journal of Global Oncology|September 23, 2018
Predictors and Prevalence of Pain and Its Management in Four Regional Cancer Hospitals in IndiaKatherine E Doyle, Shatha K El Nakib, M R Rajagopal, et al.Ecancermedicalscience|February 23, 2023
Situational analysis of the quality of palliative care services across India: a cross-sectional surveyArunangshu Ghoshal, Anjum Khan Joad, Odette Spruijt, et al.Papillomavirus Research (Amsterdam, Netherlands)|March 27, 2018
Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in IndiaNeerja Bhatla, Bhagwan M Nene, Smita Joshi, et al.Papillomavirus Research (Amsterdam, Netherlands)|February 4, 2019
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort studyPartha Basu, Richard Muwonge, Neerja Bhatla, et al.The Lancet. Oncology|December 15, 2015
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort studyRengaswamy Sankaranarayanan, Priya Ramesh Prabhu, Michael Pawlita, et al.Pageof 3